NCT04887493 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Batinelli L, Serafini A, Nante N, Petraglia F, Severi FM, Messina G
Induction of labour: clinical predictive factors for success and failure. J Obstet Gynaecol. 2018 Apr;38(3):352-358. doi: 10.1080/01443615.2017.1361388. Epub 2017 Oct 23.
Mozurkewich EL, Chilimigras JL, Berman DR, Perni UC, Romero VC, King VJ, Keeton KL
Methods of induction of labour: a systematic review. BMC Pregnancy Childbirth. 2011 Oct 27;11:84. doi: 10.1186/1471-2393-11-84. Review.
Teixeira C, Lunet N, Rodrigues T, Barros H
The Bishop Score as a determinant of labour induction success: a systematic review and meta-analysis. Arch Gynecol Obstet. 2012 Sep;286(3):739-53. doi: 10.1007/s00404-012-2341-3. Epub 2012 May 1. Review.

Efficacy and Safety of Sublingual Versus Vaginal Misoprostol for Induction of Labor for Primigravida at 41 or More Weeks of Pregnancy: A Randomized Clinical Trial

Details for clinical trial NCT04887493

Clinical trial NCT04887493 - References